{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:42:49Z","timestamp":1794915769545,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A4A1031259 and 2021R1I1A3041149"],"award-info":[{"award-number":["2022R1A4A1031259 and 2021R1I1A3041149"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A6A3A13069395"],"award-info":[{"award-number":["2022R1A6A3A13069395"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lipid metabolism, particularly fatty acid oxidation dysfunction, is a major driver of renal fibrosis. However, the detailed regulatory mechanisms underlying this process remain unclear. Here we demonstrated that acyl-CoA thioesterase 12 (Acot12), an enzyme involved in the hydrolysis of acyl-CoA thioesters into free fatty acids and CoA, is a key regulator of lipid metabolism in fibrotic kidneys. A significantly decreased level of ACOT12 was observed in kidney samples from human patients with chronic kidney disease as well as in samples from mice with kidney injuries. Acot12 deficiency induces lipid accumulation and fibrosis in mice subjected to unilateral ureteral obstruction (UUO). Fenofibrate administration does not reduce renal fibrosis in\n                    <jats:italic>Acot12<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    mice with UUO. Moreover, the restoration of peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) in\n                    <jats:italic>Acot12<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>Ppar\u03b1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    kidneys with UUO exacerbated lipid accumulation and renal fibrosis, whereas the restoration of Acot12 in\n                    <jats:italic>Acot12<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    <jats:italic>Ppar\u03b1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    kidneys with UUO significantly reduced lipid accumulation and renal fibrosis, suggesting that, mechanistically,\n                    <jats:italic>Acot12<\/jats:italic>\n                    deficiency exacerbates renal fibrosis independently of PPAR\n                    <jats:italic>\u03b1<\/jats:italic>\n                    . In\n                    <jats:italic>Acot12<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    kidneys with UUO, a reduction in the selective autophagic degradation of peroxisomes and pexophagy with a decreased level of ACBD5 was observed. In conclusion, our study demonstrates the functional role and mechanistic details of Acot12 in the progression of renal fibrosis, provides a preclinical rationale for regulating Acot12 expression and presents a novel means of preventing renal fibrosis.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01406-3","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:28:17Z","timestamp":1739399297000},"page":"478-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ACOT12, a novel factor in the pathogenesis of kidney fibrosis, modulates ACBD5"],"prefix":"10.1038","volume":"57","author":[{"given":"Ee Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MiSun","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5184-2721","authenticated-orcid":false,"given":"Eun Seon","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5601-1265","authenticated-orcid":false,"given":"Hunjoo","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6874-3017","authenticated-orcid":false,"given":"Eun-Jung","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"1406_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy, C. P. Epidemiology of chronic kidney disease: an update 2022. Kidney Int. Suppl. 12, 7\u201311 (2022).","journal-title":"Kidney Int. Suppl."},{"key":"1406_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41581-022-00590-z","volume":"18","author":"L Li","year":"2022","unstructured":"Li, L., Fu, H. & Liu, Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat. Rev. Nephrol. 18, 545\u2013557 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1406_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1681\/ASN.2009091005","volume":"22","author":"AB Farris","year":"2011","unstructured":"Farris, A. B. et al. Morphometric and visual evaluation of fibrosis in renal biopsies. J. Am. Soc. Nephrol. 22, 176\u2013186 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1406_CR4","doi-asserted-by":"publisher","first-page":"112115","DOI":"10.1016\/j.biopha.2021.112115","volume":"143","author":"H Yan","year":"2021","unstructured":"Yan, H. et al. Defining therapeutic targets for renal fibrosis: exploiting the biology of pathogenesis. Biomed. Pharmacother. 143, 112115 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"1406_CR5","doi-asserted-by":"publisher","first-page":"832732","DOI":"10.3389\/fphar.2022.832732","volume":"13","author":"J Gao","year":"2022","unstructured":"Gao, J. & Gu, Z. The role of peroxisome proliferator-activated receptors in kidney diseases. Front. Pharmacol. 13, 832732 (2022).","journal-title":"Front. Pharmacol."},{"key":"1406_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1681\/ASN.2017070802","volume":"29","author":"KW Chung","year":"2018","unstructured":"Chung, K. W. et al. Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging. J. Am. Soc. Nephrol. 29, 1223\u20131237 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1406_CR7","doi-asserted-by":"publisher","first-page":"117729","DOI":"10.1016\/j.lfs.2020.117729","volume":"253","author":"MN Makled","year":"2020","unstructured":"Makled, M. N. & El-Kashef, D. H. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-\u03b2\/Smad signaling pathway. Life Sci. 253, 117729 (2020).","journal-title":"Life Sci."},{"key":"1406_CR8","doi-asserted-by":"publisher","first-page":"F618","DOI":"10.1152\/ajprenal.00309.2013","volume":"305","author":"S Li","year":"2013","unstructured":"Li, S. et al. Proximal tubule PPAR\u03b1 attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 305, F618\u2013F627 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1406_CR9","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1093\/ndt\/gfn157","volume":"23","author":"GJ Ko","year":"2008","unstructured":"Ko, G. J. et al. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. Nephrol. Dial. Transplant 23, 2750\u20132760 (2008).","journal-title":"Nephrol. Dial. Transplant"},{"key":"1406_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5114\/amsad\/151046","volume":"7","author":"G Papaetis","year":"2022","unstructured":"Papaetis, G. Pioglitazone in diabetic kidney disease: forgotten but not gone. Arch. Med. Sci. Atheroscler. Dis. 7, 78\u201393 (2022).","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"1406_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 (2015).","journal-title":"Nat. Med."},{"key":"1406_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140695","volume":"131","author":"V Miguel","year":"2021","unstructured":"Miguel, V. et al. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J. Clin. Invest. 131, e140695 (2021).","journal-title":"J. Clin. Invest."},{"key":"1406_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","volume":"89","author":"ACP Souza","year":"2016","unstructured":"Souza, A. C. P. et al. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int. 89, 809\u2013822 (2016).","journal-title":"Kidney Int."},{"key":"1406_CR14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. Cd36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat. Rev. Nephrol. 13, 769\u2013781 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1406_CR15","doi-asserted-by":"publisher","first-page":"103162","DOI":"10.1016\/j.ebiom.2020.103162","volume":"63","author":"JJ Kim","year":"2021","unstructured":"Kim, J. J. et al. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome. EBioMedicine 63, 103162 (2021).","journal-title":"EBioMedicine"},{"key":"1406_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03850-1","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Pre-emptive pharmacological inhibition of fatty acid\u2013binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism. Cell Death Dis. 12, 572 (2021).","journal-title":"Cell Death Dis."},{"key":"1406_CR17","doi-asserted-by":"publisher","first-page":"566535","DOI":"10.3389\/fimmu.2020.566535","volume":"11","author":"Y Feng","year":"2020","unstructured":"Feng, Y. et al. Inhibition of fatty acid-binding protein 4 attenuated kidney fibrosis by mediating macrophage-to-myofibroblast transition. Front. Immunol. 11, 566535 (2020).","journal-title":"Front. Immunol."},{"key":"1406_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03199-x","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis. Cell Death Dis. 11, 994 (2020).","journal-title":"Cell Death Dis."},{"key":"1406_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27738-y","volume":"13","author":"S Park","year":"2022","unstructured":"Park, S., Baek, I. J., Ryu, J. H., Chun, C. H. & Jin, E. J. PPAR\u03b1\u2212ACOT12 axis is responsible for maintaining cartilage homeostasis through modulating de novo lipogenesis. Nat. Commun. 13, 3 (2022).","journal-title":"Nat. Commun."},{"key":"1406_CR20","doi-asserted-by":"publisher","first-page":"153393","DOI":"10.1016\/j.phymed.2020.153393","volume":"80","author":"S Jiang","year":"2021","unstructured":"Jiang, S. et al. Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle\u2013kidney crosstalk. Phytomedicine 80, 153393 (2021).","journal-title":"Phytomedicine"},{"key":"1406_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1\u201313 (2009).","journal-title":"Nucleic Acids Res."},{"key":"1406_CR22","first-page":"F254","volume":"14","author":"J Tannenbaum","year":"1983","unstructured":"Tannenbaum, J., Purkerson, M. L. & Klahr, S. Effect of unilateral ureteral obstruction on metabolism of renal lipids in the rat. Am. J. Physiol. 14, F254\u2013F262 (1983).","journal-title":"Am. J. Physiol."},{"key":"1406_CR23","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.cmet.2022.09.026","volume":"34","author":"H Li","year":"2022","unstructured":"Li, H., Dixon, E. E., Wu, H. & Humphreys, B. D. Comprehensive single-cell transcriptional profiling defines shared and unique epithelial injury responses during kidney fibrosis. Cell Metab. 34, 1977\u20131998.e9 (2022).","journal-title":"Cell Metab."},{"key":"1406_CR24","doi-asserted-by":"publisher","first-page":"112931","DOI":"10.1016\/j.biopha.2022.112931","volume":"149","author":"J Zou","year":"2022","unstructured":"Zou, J., Zhou, X., Ma, Y. & Yu, R. Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-\u03b2\/Smad. Biomed. Pharmacother. 149, 112931 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1406_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.actbio.2015.08.043","volume":"27","author":"JH Ryu","year":"2015","unstructured":"Ryu, J. H., Hong, S. & Lee, H. Bio-inspired adhesive catechol-conjugated chitosan for biomedical applications: a mini review. Acta Biomater. 27, 101\u2013115 (2015).","journal-title":"Acta Biomater."},{"key":"1406_CR26","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1406_CR27","doi-asserted-by":"publisher","first-page":"805281","DOI":"10.3389\/fphar.2022.805281","volume":"13","author":"Z Gao","year":"2022","unstructured":"Gao, Z. & Chen, X. Fatty acid \u03b2-oxidation in kidney diseases: perspectives on pathophysiological mechanisms and therapeutic opportunities. Front. Pharmacol. 13, 805281 (2022).","journal-title":"Front. Pharmacol."},{"key":"1406_CR28","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fphys.2020.00794","volume":"11","author":"L Console","year":"2020","unstructured":"Console, L. et al. The link between the mitochondrial fatty acid oxidation derangement and kidney injury. Front. Physiol. 11, 794 (2020).","journal-title":"Front. Physiol."},{"key":"1406_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmed.2020.00065","volume":"7","author":"HS Jang","year":"2020","unstructured":"Jang, H. S., Noh, M. R., Kim, J. & Padanilam, B. J. Defective mitochondrial fatty acid oxidation and lipotoxicity in kidney diseases. Front. Med. 7, 65 (2020).","journal-title":"Front. Med."},{"key":"1406_CR30","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1681\/ASN.2018010050","volume":"29","author":"M Lee","year":"2018","unstructured":"Lee, M.et al. Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin. J. Am. Soc. Nephrol. 29, 2326\u20132336 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1406_CR31","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161783","volume":"7","author":"A Rinaldi","year":"2022","unstructured":"Rinaldi, A. et al. Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury. JCI Insight 7, e161783 (2022).","journal-title":"JCI Insight"},{"key":"1406_CR32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.bbadis.2012.03.009","volume":"1822","author":"MC Hunt","year":"2012","unstructured":"Hunt, M. C., Siponen, M. I. & Alexson, S. E. H. The emerging role of acyl-CoA thioesterases and acyltransferases in regulating peroxisomal lipid metabolism. Biochim. Biophys. Acta 1822, 1397\u20131410 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"1406_CR33","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s12276-021-00648-1","volume":"53","author":"S Park","year":"2021","unstructured":"Park, S. et al. Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue. Exp. Mol. Med. 53, 1159\u20131169 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1406_CR34","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cmet.2018.12.019","volume":"29","author":"M Lu","year":"2019","unstructured":"Lu, M. et al. ACOT12-dependent alteration of acetyl-CoA drives hepatocellular carcinoma metastasis by epigenetic induction of epithelial\u2013mesenchymal transition. Cell Metab. 29, 886\u2013900.e5 (2019).","journal-title":"Cell Metab."},{"key":"1406_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11960","volume":"7","author":"X Gao","year":"2016","unstructured":"Gao, X. et al. Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat. Commun. 7, 11960 (2016).","journal-title":"Nat. Commun."},{"key":"1406_CR36","first-page":"452","volume":"75","author":"KW Chung","year":"2020","unstructured":"Chung, K. W. et al. PPAR\u03b1\/\u03b2 activation alleviates age-associated renal fibrosis in sprague dawley rats. J. Gerontol. A Biol. Sci. Med. Sci. 75, 452\u2013458 (2020).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1406_CR37","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1681\/ASN.2013101068","volume":"25","author":"Y Ding","year":"2014","unstructured":"Ding, Y. et al. Autophagy regulates TGF-\u03b2 expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction. J. Am. Soc. Nephrol. 25, 2835\u20132846 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1406_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-018-0065-2","volume":"4","author":"Q Yan","year":"2018","unstructured":"Yan, Q. et al. Autophagy activation contributes to lipid accumulation in tubular epithelial cells duringkidney fibrosis. Cell Death Discov 4, 39 (2018).","journal-title":"Cell Death Discov"},{"key":"1406_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang, C., Livingston, M. J., Liu, Z. & Dong, Z. Autophagy in kidney homeostasis and disease. Nat. Rev. Nephrol. 16, 489\u2013508 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"1406_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.freeradbiomed.2019.12.005","volume":"152","author":"S Li","year":"2020","unstructured":"Li, S. et al. Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction. Free Radic. Biol. Med. 152, 632\u2013649 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"1406_CR41","first-page":"30","volume":"53","author":"G Mari\u00f1o","year":"2020","unstructured":"Mari\u00f1o, G. et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol. Cell 53, 30\u201342 (2020).","journal-title":"Mol. Cell"},{"key":"1406_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cmet.2014.02.010","volume":"19","author":"T Eisenberg","year":"2014","unstructured":"Eisenberg, T. et al. Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme A stimulates autophagy and prolongs lifespan. Cell Metab. 19, 431\u2013444 (2014).","journal-title":"Cell Metab."},{"key":"1406_CR43","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3390\/ijms21020578","volume":"21","author":"K Germain","year":"2020","unstructured":"Germain, K. & Kim, P. K. Pexophagy: a model for selective autophagy. Int. J. Mol. Sci. 21, 578 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1406_CR44","doi-asserted-by":"publisher","first-page":"814047","DOI":"10.3389\/fcell.2021.814047","volume":"9","author":"H Li","year":"2021","unstructured":"Li, H. et al. The peroxisome\u2013autophagy redox connection: a double-edged sword? Front. Cell Dev. Biol. 9, 814047 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1406_CR45","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.jhep.2016.05.046","volume":"65","author":"TV Zutphen","year":"2016","unstructured":"Zutphen, T. V. et al. Malnutrition-associated liver steatosis and ATP depletion is caused by peroxisomal and mitochondrial dysfunction. J. Hepatol. 65, 1198\u20131208 (2016).","journal-title":"J. Hepatol."},{"key":"1406_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/ars.2012.4768","volume":"19","author":"R Vasko","year":"2013","unstructured":"Vasko, R. et al. Endothelial peroxisomal dysfunction and impaired pexophagy promotes oxidative damage in lipopolysaccharide-induced acute kidney injury. Antioxid. Redox Signal. 19, 211\u2013230 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"1406_CR47","doi-asserted-by":"publisher","first-page":"577637","DOI":"10.3389\/fcell.2020.577637","volume":"8","author":"AS Azadi","year":"2020","unstructured":"Azadi, A. S. et al. A functional SMAD2\/3 binding site in the PEX11\u03b2 promoter identifies a role for TGF\u03b2 in peroxisome proliferation in humans. Front. Cell Dev. Biol. 8, 577637 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1406_CR48","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1083\/jcb.201307050","volume":"204","author":"TY Nazarko","year":"2014","unstructured":"Nazarko, T. Y. et al. Peroxisomal Atg37 binds Atg30 or palmitoyl-CoA to regulate phagophore formation during pexophagy. J. Cell Biol. 204, 541\u2013557 (2014).","journal-title":"J. Cell Biol."},{"key":"1406_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/jmedgenet-2016-104132","volume":"54","author":"S Ferdinandusse","year":"2017","unstructured":"Ferdinandusse, S. et al. ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism. J. Med. Genet. 54, 330\u2013337 (2017).","journal-title":"J. Med. Genet."},{"key":"1406_CR50","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.mayocp.2018.12.024","volume":"94","author":"J Neugarten","year":"2019","unstructured":"Neugarten, J. & Golestaneh, L. Influence of sex on the progression of chronic kidney disease. Mayo Clin. Proc. 94, 1339\u20131356 (2019).","journal-title":"Mayo Clin. Proc."},{"key":"1406_CR51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1681\/ASN.V112319","volume":"11","author":"J Neugarten","year":"2000","unstructured":"Neugarten, J., Acharya, A. & Silbiger, S. R. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J. Am. Soc. Nephrol. 11, 319\u2013329 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1406_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01594-x","volume":"18","author":"JV Zhao","year":"2020","unstructured":"Zhao, J. V. & Schooling, C. M. The role of testosterone in chronic kidney disease and kidney function in men and women: a bi-directional Mendelian randomization study in the UK Biobank. BMC Med. 18, 122 (2020).","journal-title":"BMC Med."},{"key":"1406_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155836","volume":"7","author":"C Ansermet","year":"2022","unstructured":"Ansermet, C. et al. Renal tubular peroxisomes are dispensable for normal kidney function. JCI Insight 7, e155836 (2022).","journal-title":"JCI Insight"},{"key":"1406_CR54","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.34067\/KID.0003772021","volume":"360","author":"P Ranea-Robles","year":"2021","unstructured":"Ranea-Robles, P. et al. Peroxisomal L-bifunctional protein deficiency causes male-specific kidney hypertrophy and proximal tubular injury in mice. Kidney 360, 1441\u20131454 (2021).","journal-title":"Kidney"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01406-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01406-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01406-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:04:01Z","timestamp":1761717841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01406-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1406"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01406-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"28 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Supplementary Information file has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}